BridgeBio Pharma, Inc. SEC filings BBIO

BridgeBio Pharma, Inc. has 833 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

BridgeBio Pharma, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Oct 30, 2026
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 27, 2026 —
8-K Current report
Other events
Oct 13, 2026 Oct 6, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
8-K Current report
Other events
Aug 31, 2026 Aug 31, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 19, 2026 —
4 Insider transaction Aug 18, 2026 Aug 16, 2026
4 Insider transaction Aug 18, 2026 Aug 16, 2026
4 Insider transaction Aug 18, 2026 Aug 16, 2026
144 Notice of proposed sale Aug 18, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 17, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
8-K Current report
Material agreement, Other events
Aug 17, 2026 Aug 13, 2026
424B7 Filing Aug 14, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 3, 2026 Jul 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
S-3ASR Automatic shelf registration Jul 24, 2026 —
S-8 Employee stock plan registration Jul 24, 2026 —
8-K Current report
Other events
Jul 22, 2026 Jul 22, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 10, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Jul 2, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 26, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 23, 2026 Jun 20, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 8, 2026 Jun 4, 2026
SCHEDULE 13G Ownership over 5% (passive) May 29, 2026 —
8-K Current report
Other events
May 27, 2026 May 27, 2026
4 Insider transaction May 26, 2026 May 21, 2026
144 Notice of proposed sale May 21, 2026 —
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 15, 2026
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Other events
May 13, 2026 May 12, 2026
4 Insider transaction May 11, 2026 May 7, 2026
8-K Current report
Material agreement, Agreement ended
May 8, 2026 May 7, 2026
S-3ASR Automatic shelf registration May 8, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Other events
May 7, 2026 May 6, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Jun 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 16, 2026 —
4 Insider transaction Apr 13, 2026 Apr 9, 2026
144 Notice of proposed sale Apr 9, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2026 —
8-K Current report
Other events
Mar 30, 2026 Mar 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
144 Notice of proposed sale Mar 13, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 10, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 27, 2026 Feb 26, 2026
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 24, 2026 Feb 24, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 12, 2026 Feb 10, 2026
8-K Current report
Other events
Feb 12, 2026 Feb 12, 2026
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Jan 21, 2026 Jan 14, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 12, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 14, 2025 —
4 Insider transaction Nov 14, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
4 Insider transaction Nov 7, 2025 Nov 6, 2025
144 Notice of proposed sale Nov 6, 2025 —
4 Insider transaction Oct 31, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 29, 2025 —
4 Insider transaction Oct 29, 2025 Oct 27, 2025
10-Q Quarterly report Oct 29, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Results of operations
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Oct 27, 2025 Oct 27, 2025
144 Notice of proposed sale Oct 27, 2025 —
4 Insider transaction Oct 16, 2025 Oct 10, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
144 Notice of proposed sale Oct 8, 2025 —
144 Notice of proposed sale Oct 8, 2025 —
4 Insider transaction Sep 8, 2025 Sep 5, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 5, 2025 —
4 Insider transaction Aug 22, 2025 Aug 21, 2025
4 Insider transaction Aug 22, 2025 Aug 20, 2025
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 19, 2025 Aug 16, 2025
4 Insider transaction Aug 19, 2025 Aug 16, 2025
4 Insider transaction Aug 19, 2025 Aug 16, 2025
3 Initial insider ownership Aug 18, 2025 Aug 11, 2025
144 Notice of proposed sale Aug 18, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
144 Notice of proposed sale Aug 11, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
4 Insider transaction Aug 7, 2025 Aug 5, 2025
S-8 Employee stock plan registration Aug 5, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
144 Notice of proposed sale Aug 5, 2025 —
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
8-K Current report
Material agreement, New debt
Jul 2, 2025 Jun 27, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 1, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jul 1, 2025 —
4 Insider transaction Jun 30, 2025 Jun 27, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4/A Filing Jun 30, 2025 Dec 29, 2021
4/A Filing Jun 30, 2025 Dec 28, 2021
4 Insider transaction Jun 26, 2025 Jun 24, 2025
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
144 Notice of proposed sale Jun 24, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jun 23, 2025 Jun 20, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Large accelerated filer
SEC CIK
1743881
Former names
BridgeBio Pharma LLC (until May 16, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.